TGFB1 and inflammatory bowel disease: IL-21 was found essential in patients of inflammatory bowel diseases (IBD) in promoting IL-17 production in anti-CD3/CD28-stimulated LPMCs, whereas IL-1β, IL-6, IL-23 and TGF-β exerted no effects [34].